Medtronic plc Cash and Cash Equivalents, Period Increase (Decrease)
Medtronic plc (MDT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $687.00 million for the 3-month period ending 2019-07-26, per its 10-Q filed 2019-08-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-30
- Medtronic plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-07-26 was $687.00M, a 3.38% decline year-over-year.
- Medtronic plc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-01-25 was -$208.00M, a 125.09% decline year-over-year.
- Medtronic plc cash and cash equivalents, period increase (decrease) for the quarter ending 2018-10-26 was -$469.00M, a 155.97% decline year-over-year.
- Medtronic plc cash and cash equivalents, period increase (decrease) for the quarter ending 2018-07-27 was $711.00M.
- Medtronic plc cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$1.30B, a 162.08% decline from fiscal 2017.
- Medtronic plc cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.09B.
- Medtronic plc cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.97B, a 157.18% decline from fiscal 2015.
- Medtronic plc cash and cash equivalents, period increase (decrease) for fiscal 2015 was $3.44B, a 610.74% increase from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 7 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2019-07-26 | $687.00M 10-Q · filed 2019-08-30 | ||||
| 2019-01-25 | -$208.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | -$677.00M derived: sum of 2 quarters · filed 2019-03-01 | $34.00M 10-Q · filed 2019-03-01 | -$2.65B derived: sum of 4 quarters · filed 2019-08-30 | |
| 2018-10-26 | -$469.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | $242.00M 10-Q · filed 2018-11-29 | -$2.45B derived: sum of 3 quarters · filed 2019-08-30 | -$1.62B derived: sum of 4 quarters · filed 2019-08-30 | |
| 2018-07-27 | $711.00M 10-Q · filed 2019-08-30 | -$1.98B derived: sum of 2 quarters · filed 2019-08-30 | -$1.15B derived: sum of 3 quarters · filed 2019-08-30 | -$311.00M derived: sum of 4 quarters · filed 2019-08-30 | |
| 2018-04-27 | -$2.69B derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | -$1.86B derived: sum of 2 quarters · filed 2019-03-01 | -$1.02B derived: sum of 3 quarters · filed 2019-03-01 | -$1.30B 10-K · filed 2018-06-22 | |
| 2018-01-26 | $829.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | $1.67B derived: sum of 2 quarters · filed 2019-03-01 | $1.39B 10-Q · filed 2019-03-01 | $3.59B derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-10-27 | $838.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | $562.00M 10-Q · filed 2018-11-29 | $2.76B derived: sum of 3 quarters · filed 2018-11-29 | $2.58B derived: sum of 4 quarters · filed 2018-11-29 | |
| 2017-07-28 | -$276.00M 10-Q · filed 2018-08-31 | $1.92B derived: sum of 2 quarters · filed 2018-08-31 | $1.74B derived: sum of 3 quarters · filed 2018-08-31 | $1.63B derived: sum of 4 quarters · filed 2018-08-31 | |
| 2017-04-28 | $2.20B derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | $2.01B derived: sum of 2 quarters · filed 2018-06-22 | $1.91B derived: sum of 3 quarters · filed 2018-06-22 | $2.09B 10-K · filed 2018-06-22 | |
| 2017-01-27 | -$186.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | -$292.00M derived: sum of 2 quarters · filed 2018-03-02 | -$108.00M 10-Q · filed 2018-03-02 | $47.00M derived: sum of 4 quarters · filed 2018-06-22 | |
| 2016-10-28 | -$106.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | $78.00M 10-Q · filed 2017-12-04 | $233.00M derived: sum of 3 quarters · filed 2018-06-22 | $576.00M derived: sum of 4 quarters · filed 2018-06-22 | |
| 2016-07-29 | $184.00M 10-Q · filed 2017-09-01 | $339.00M derived: sum of 2 quarters · filed 2018-06-22 | $682.00M derived: sum of 3 quarters · filed 2018-06-22 | $81.00M derived: sum of 4 quarters · filed 2018-06-22 | |
| 2016-04-29 | $155.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | $498.00M derived: sum of 2 quarters · filed 2018-06-22 | -$103.00M derived: sum of 3 quarters · filed 2018-06-22 | -$1.97B 10-K · filed 2018-06-22 | |
| 2016-01-29 | $343.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-03 | -$258.00M derived: sum of 2 quarters · filed 2017-03-03 | -$2.12B 10-Q · filed 2017-03-03 | -$14.51B derived: sum of 4 quarters · filed 2017-06-27 | |
| 2015-10-30 | -$601.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-05 | -$2.46B 10-Q · filed 2016-12-05 | -$14.85B derived: sum of 3 quarters · filed 2017-06-27 | $1.09B derived: sum of 4 quarters · filed 2017-06-27 | |
| 2015-07-31 | -$1.86B 10-Q · filed 2016-09-07 | -$14.25B derived: sum of 2 quarters · filed 2017-06-27 | $1.69B derived: sum of 3 quarters · filed 2017-06-27 | $1.64B derived: sum of 4 quarters · filed 2017-06-27 | |
| 2015-04-24 | -$12.39B derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-27 | $3.56B derived: sum of 2 quarters · filed 2017-06-27 | $3.51B derived: sum of 3 quarters · filed 2017-06-27 | $3.44B 10-K · filed 2017-06-27 | |
| 2015-01-23 | $15.94B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-09 | $15.89B derived: sum of 2 quarters · filed 2016-03-09 | $46.00K 10-Q · filed 2015-02-27 | $15.83B 10-Q · filed 2016-03-09 | |
| 2014-10-24 | -$49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-09 | -$116.00M 10-Q · filed 2015-12-09 | |||
| 2014-07-25 | -$67.00M 10-Q · filed 2015-09-09 | ||||
| 2014-04-25 | $484.00M 10-K · filed 2016-06-28 | ||||
| 2013-04-26 | -$253.00M 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |